Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Glivec in High-Risk Localized GIST
NCT00278876Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Apr 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Asan Medical Center. Started Apr 2005; status: completed.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00278876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278876.